Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore key tips on what not to do when planning for retirement. Avoid common missteps to ensure a successful retirement.
26,407 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
The Ethereum Foundation lays out a 2026 roadmap centered on post-quantum security and bigger gas limits, reorganizing...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Bitwise CIO Matt Hougan says the crypto winter persists, but fundamentals are strengthening, laying the groundwork fo...
A surprise accounting disclosure sent Driven Brands shares skidding. This guide breaks down what happened, how to ass...
A new study from Engel & Volkers tracks how the next generation of high-earning buyers is overturning luxury home tre...
BitGo is lining up a $2 billion IPO and seeking an OCC national bank charter, while facing competition from Morgan St...
Constellation Energy plunged today after a mix of macro moves and strategic shifts. This guide breaks down the factor...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
Costco combines a members-only model with scale and efficiency. This article examines the odds that will costco whole...
A firsthand look at NAR's leadership transition reveals a new operating tempo and renewed focus on accountability. Th...
A fresh analysis places the calendar of tax season squarely in the economic spotlight, revealing a $146 billion burde...